Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

endocrine · Mechanism Report

Does the FSHB rs10835638-T promoter variant alter FSH levels, menstrual cycle length, and age at menopause?

The rs10835638-T allele reduces FSHB promoter activity, is associated with lower circulating FSH, longer menstrual cycles, and a later age at natural menopause.

SupportedJune 19, 20267 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

FSHB rs10835638 is a promoter variant associated with differences in follicle-stimulating hormone levels and reproductive traits such as menstrual cycle length and age at menopause.

laying out figure…
All 6 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim reports that a promoter polymorphism in FSHB impairs transcription factor binding, lowering gene expression and circulating FSH. This hormonal change is linked to modestly longer menstrual cycles and a delayed timing of natural menopause, consistent with slower follicle recruitment and depletion. The mechanism frames the genetic effect as reduced promoter activity leading to downstream reproductive-timeline shifts.

Verified conclusion

The FSHB rs10835638 (c.-211G>T) variant is a functional polymorphism located in the promoter region of the gene encoding the follicle-stimulating hormone (FSH) beta-subunit. As a primary regulator of the hypothalamic-pituitary-gonadal (HPG) axis, variations in this gene have measurable impacts on reproductive lifespan and hormonal profiles.

Clinical evidence

Large-scale genome-wide association studies (GWAS) and meta-analyses, including data from the UK Biobank, have robustly linked the rs10835638-T allele to significant shifts in reproductive milestones:

  • FSH Levels: The T allele is strongly associated with lower circulating serum FSH levels. In female cohorts, this hormonal shift directly influences follicular dynamics.
  • Menstrual Cycle Length: Each T allele is associated with an increase in menstrual cycle length of approximately 0.16 standard deviations (roughly 1 day per allele). This association has reached genome-wide significance (P < 5 × 10⁻⁸).
  • Age at Menopause: The same variant significantly influences the timing of natural menopause. Carriers of the T allele typically experience menopause later than those with the GG genotype, with an estimated delay of 0.13 years per T allele.

Mechanistic explanations

The variant functions by modulating the transcriptional efficiency of the FSHB gene through a specific molecular pathway:

  • Transcription Factor Binding: The rs10835638 locus resides within a binding site for LHX3, a homeodomain transcription factor essential for pituitary hormone expression.
  • Promoter Activity: The wild-type G allele exhibits high binding affinity for LHX3. The T allele significantly impairs this binding, leading to reduced promoter activity and lower basal transcription of FSHB.
  • Follicular Dynamics: Lower FSH levels resulting from this reduced transcription are thought to slow the rate of follicle recruitment and depletion, which mechanistically explains the extension of both cycle length and the overall reproductive lifespan.

Bottom line

The FSHB rs10835638-T allele is a validated genetic marker for lower FSH levels, longer menstrual cycles, and a later age at natural menopause. For a 45-year-old female, this variant may provide insight into individual variations in the timing of the menopausal transition and late-career reproductive health.

References

  1. A human FSHB promoter SNP associated with low FSH levels in men impairs LHX3 binding and basal FSHB transcription. — pmc.ncbi.nlm.nih.gov ↗
  2. Genetic evidence that lower circulating FSH levels lengthen menstrual cycle, increase age at menopause and impact female reproductive health — pmc.ncbi.nlm.nih.gov ↗
  3. Increased Prevalance of the -211 T allele of follicle stimulating hormone (FSH) beta subunit promoter polymorphism and lower serum FSH in infertile men. — pmc.ncbi.nlm.nih.gov ↗
  4. FSHB promoter polymorphism within evolutionary conserved element is associated with serum FSH level in men — pmc.ncbi.nlm.nih.gov ↗
  5. Genetic evidence that lower circulating FSH levels lengthen menstrual cycle, increase age at menopause and impact female reproductive health — academic.oup.com ↗
  6. Genetic evidence that lower circulating FSH levels lengthen menstrual cycle, increase age at menopause, and impact reproductive health: a UK Biobank study — biorxiv.org ↗
  7. Large-scale meta-analysis highlights the hypothalamic–pituitary–gonadal axis in the genetic regulation of menstrual cycle length — academic.oup.com ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible8 sourcesCan obstructive sleep apnea lower testosterone in men?→Plausible5 sourcesDoes a non-elevated LH with low testosterone suggest secondary hypogonadism?→